Abstract:Objectives Early identification of sarcopenia in patients with chronic liver disease is crucial for patient management and prevention of severe complications. We aimed to assess the comparative accuracy of using Ishii score, Strength, Assistance with Walking, Rise from a Chair, Climb Stairs and Falls (SARC-F), SARC-F and Calf Circumference (SARC-CalF), and Mini Sarcopenia Risk Assessment-7 (MSRA-7) to screen sarcopenia in patients with chronic liver disease. Methods This was a prospective study that included patients with chronic liver disease in the infectious department of a third-class hospital in Sichuan Province. Ishii score, SARC-F, SARC-CalF, and MSRA-7 were used to screen for sarcopenia risk. Sarcopenia was diagnosed according to the Asian Myometriosis Working Group (AWGS) 2019, which was used as the gold standard to compare the performance of the four screening tools. We completed clinical registration on the Chinese Clinical Trial Registration website (ChiCTR2100043910). Results A total of 366 patients with chronic liver disease (22.4 % women, mean age 48.96 ± 11.88 years) were evaluated. Based on the AWGS 2019 standard, the prevalence of sarcopenia in patients with chronic liver disease was 17.5 %. Among all participants, receiver operating characteristic (ROC) produced an area under the curve (AUC) of 0.820 for Ishii score (sensitivity 85.94 %, specificity 78.15 %), 0.528 for SARC-F (sensitivity 6.25 %, specificity 99.34 %), 0.642 for SARC-CalF (sensitivity 45.31 %, specificity 83.11 %), and 0.552 for MSRA-7 (sensitivity 87.50 %, specificity 22.85 %). Based on AUC, decision curve analysis (DCA), and calibration curves, we concluded that Ishii score was the most accurate screening tool and was superior to the other tools. Conclusions Ishii score is more suitable for screening sarcopenia in patients with chronic liver disease than the SARC-F, SARC-CalF, and MSRA-7, based on the AWGS 2019 criteria. Nursing professionals can use Ishii score as a clinical tool to screen for sarcopenia in patients with chronic liver disease, providing an indication cue for the final diagnosis of sarcopenia to improve diagnostic efficiency and achieve the goal of early identification and prevention of complications resulting from sarcopenia.

Comparison of the ability between dual‐energy X‐ray absorptiometry and bioelectrical impedance analysis for diagnosing low skeletal muscle mass and sarcopenia in patients with chronic liver disease

Optimal Skeletal Muscle Mass Index Cut-Off Values for Presarcopenia Evaluated by Computed Tomography against Dual-Energy X-ray Absorptiometry in Patients with Chronic Liver Disease

Assessing Lean Tissue by Bioelectrical Impedance Analysis Pre Hemodialysis Underestimates the Prevalence of Sarcopenia in Maintenance Hemodialysis Patients

Reliability and Agreement Assessment of Sarcopenia Diagnosis through Comparison of Bioelectrical Impedance Analysis and Dual-Energy X-ray Absorptiometry

Prognostic values of muscle mass assessed by dual‐energy X‐ray absorptiometry and bioelectrical impedance analysis in older patients with heart failure

Bioelectrical impedance analysis and dual x-ray absorptiometry agreement for skeletal muscle mass index evaluation in sarcopenia diagnosis

Bioelectrical Impedance Analysis Demonstrates Reliable Agreement with Dual-Energy X-ray Absorptiometry in Identifying Reduced Skeletal Muscle Mass in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease and Hypertension

Case finding for sarcopenia in geriatric inpatients: performance of bioimpedance analysis in comparison to dual X-ray absorptiometry

Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis

Comparison of the performance of four screening tools for sarcopenia in patients with chronic liver disease

Open, Active-Controlled Clinical Study to Evaluate the Correlation between Whole Body DEXA and BIA Muscle Measurements

Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank

Comparison of single- or multifrequency bioelectrical impedance analysis and spectroscopy for assessment of appendicular skeletal muscle in the elderly

Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphoma

Agreement and diagnostic differences among three definitions of sarcopenia in patients with chronic hepatitis C

The Performance of Five Bioelectrical Impedance Analysis Prediction Equations against Dual X-ray Absorptiometry in Estimating Appendicular Skeletal Muscle Mass in an Adult Australian Population

Assessment of Skeletal Muscle Mass in Older People: Comparison Between 2 Anthropometry-Based Methods and Dual-Energy X-ray Absorptiometry

Sarcopenia prognosis using dual‐energy X‐ray absorptiometry and prediction model in older patients with heart failure

Comparative analysis of Sarcopenia in hospitalized elderly: exploring the impact of liver cirrhosis

Validity of bioelectric impedance analysis for body composition assessment in interstitial lung disease patients

Mid-Upper Arm Circumference as an Alternative Screening Instrument to Appendicular Skeletal Muscle Mass Index for Diagnosing Sarcopenia